Abstract:Objective To investigate the relationship between fasting blood glucose (FBG),glycosylated serum protein(GSP),blood lipids and diabetic retinopathy(DR) in non-insulin dependent diabetes mellitus(type 2 diabetics ).Methods According to a retinopathy examination,the 128 cases of type 2 diabetics were divided into the DR group (66 cases) and the non-DR group (62 cases),respectively.They were separately compared with the normal controls (58 subjects) and observed the changes in FBG,GSP and blood lipids.Results FBG levels in both DR group and non-DR group were (8.92±2.86)mmol·L-1 and (9.24±3.11)mmol·L-1,respectively.Although these two measurement did not illustrate a significantly difference(P0.05),they were significantly higher than in the normal controls,where FBG level was (4.52±0.84)mmol·L-1(P0.01).GSP concentrations both in non-DR group (250.2±43.6)μmol·L-1 and in the normal controls (237.3±36.8)μmol·L-1 were similar(P0.05),but they were significantly lower than in DR group (385.6±61.4)μmol·L-1(P0.01).In non-DR group and DR group,where the level of TG were (1.96±0.86)mmol·L-1 and (2.32±0.98)mmol·L-1 compared with (1.36±0.67)mmol·L-1in controls;The level of TC were (5.62±1.02)mmol·L-1 and (6.36±1.08)mmol·L-1 compared with (4.13±0.96)mmol·L-1in controls;The level of LDL-C were (3.89±0.94)mmol·L-1 and (4.21±1.02)mmol·L-1 compared with (3.36±0.86)mmol·L-1 in controls;The level of VLDL-C were(0.54±0.04)mmol·L-1 and (0.79±0.05)mmol·L-1 compared with (0.35±0.02)mmol·L-1 in controls.However,a reversed direction was observed in HDL-C with (1.02±0.03)mmol·L-1 in non-DR group and (0.86±0.02)mmol·L-1 in DR group compared with (1.38±0.05) mmol·L-1 in the controls(P0.01).A further laboratory test verified that the TG,TC and VLDL-C levels were significantly higher in DR group than in non-DR group(P0.01).However,HDL-C concentration was significantly lower in DR than in non-DR(P0.01),and LDL-C concentrations in both DR group and non-DR group did not illustrate a significantly difference(P0.05).Conclusion A relationship between high FBG,high GSP and the metabolic disorder of blood lipids was confirmed in our clinic observational study.

Relationship of Non-Hdl、rbp and SF with Type 2 Diabetes Combined with Nonalcoholic Fatty Liver Disease

Relationship between Nonalcoholic Fatty Liver Disease and Abnormality of Glycolipid Metabolism

Association of Nonalcoholic Fatty Liver Disease with Type 2 Diabetes: Clinical Features and Independent Risk Factors in Diabetic Fatty Liver Patients.

A study on the association between nonalcoholic fatty liver disease and the levels of sex hormones among patients with type 2 diabetes mellitus

[Relationship Between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease in Children with Obesity].

Clinical characters and risk factors of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus

Study on the Relations Between Abnormality of Insulin Resistance, Serum Leptin and Fatty Liver in Type 2 Diabetes Mellitus

Relationship Between Fasting Blood Glucose, Glycosylated Serum Protein, Blood Lipid and Diabetic Retinopathy in Type 2 Diabetics

Relationship Between Nonalcoholic Fatty Liver Disease and Metabolic Syndrome.

The relationship between nonalcoholic fatty liver disease and insulin resistance

Relations between atherosclerosis and nonalcoholic fatty liver disease in Type 2 diabetes subjects

Serum phospholipid omega-3 polyunsaturated fatty acids and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease

Extrapolation of two-factor learning theory of infrahuman avoidance behavior to psychopathology

Association Between Non-Alcoholic Fatty Liver Disease and Diabetes-Related Microvascular Complications: A Retrospective Cross-Sectional Study of Hospitalized Patients.

IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE.

Risk factors fornon-alcoholic fatty liver disease in patients with type 2 diabetes mellitus

Increased expression of blood serum free fatty acids and cytokeratin 18 in patients with type 2 diabetes with non alcoholic fatty liver disease

Comparison of Different Non-Invasive Hepatic Fibrosis Evaluation Criteria for the Evaluation of Hepatic Fibrosis in Patients with Type 2 Diabetes Mellitus Combined with Non-Alcoholic Fatty Liver Disease

The relationship between liver fat content and liver disease outcome in patients with type 2 diabetes

Association of iron overload with non-alcoholic fatty liver disease in patients with type 2 diabetes

Prevalence of nonalcoholic fatty liver disease and liver cirrhosis in Chinese adults with type 2 diabetes mellitus